Table 2.

Disease characteristics of patients with cancer with COVID-19 and association with mortality

AliveDeceasedP
Total157 (72%)61 (28%)
 Males91 (72%)36 (28%)0.6
 Females66 (73%)25 (27%)0.6
Median age (range)66 (10–92)76 (10–92)0.0006
Race0.602
 Caucasian14 (64%)8 (36%)
 Hispanic58 (76%)18 (24%)
 African American67 (73%)25 (27%)
 Asian5 (71%)2 (29%)
 Other13 (62%)8 (38%)
N/total alive (%)N/total deceased (%)
ICU admission8 (5%)15 (24%)9.10E-05
Ventilator support10 (6%)35 (57%)1.74E-15
Hemodialysis10 (6%)6 (10%)0.37
Metastasis (solids only)27 (22%)15 (37%)0.06
Active cancer (<1 yr)60 (38%)32 (52%)0.09
Active chemotherapy34 (22%)8 (13%)0.2
Immunotherapy4 (3%)1 (2%)1
Radiotherapy38 (24%)11 (18%)0.33
DM53 (34%)27 (44%)0.116
HTN100 (64%)47 (77%)0.047
Chronic lung disease34 (22%)28 (46%)0.0003
Chronic kidney disease33 (21%)21 (34%)0.052
Coronary artery disease24 (15%)19 (31%)0.012
CHF18 (11%)15 (25%)0.019